The Director General of the Nigeria Centre for Disease Control and Prevention (NCDC), Dr. Jide Idris, raised the alarm during the 14th Ministerial Oversight Committee meeting on the Basic Health Care Provision Fund (BHCPF) in Abuja on Tuesday.
Vaccine Mismatch Raises Concern
Dr. Idris noted that while vaccination continues to be a key preventive measure, existing vaccine formulations do not fully match the circulating serogroup C strain. “Additional strategies are needed to effectively control ongoing outbreaks,” he said.
According to national surveillance data and the World Health Organization (WHO), meningitis remains a seasonal public health challenge in Nigeria, peaking between December and April when dry, dusty conditions and overcrowded living spaces facilitate transmission.
Shifting Strains and High-Risk Groups
Outbreaks are now largely driven by serogroup C, which has replaced the previously dominant serogroup A. Other strains—including W, X, and Y—account for comparatively fewer cases. Children, young adults, and people in crowded environments are considered high-risk populations.
Strengthening Surveillance and Response
NCDC has intensified nationwide surveillance, with laboratory testing conducted at state levels while efforts continue to enhance national laboratory capacity for timely detection and confirmation of cases.
“Meningitis is a severe infection affecting the membranes covering the brain and spinal cord. It spreads through respiratory droplets in close contact, especially in overcrowded or poorly ventilated areas,” Dr. Idris said. He warned that the disease can progress rapidly and become fatal within hours if untreated, emphasizing that early diagnosis and prompt antibiotic therapy can significantly improve survival and reduce complications.
Public Advisory and Preventive Measures
Dr. Idris urged Nigerians to seek immediate medical attention if they experience symptoms such as sudden fever, severe headache, neck stiffness, nausea, vomiting, confusion, seizures, or sensitivity to light. He cautioned against automatically attributing fever and headache to malaria during the dry season, stressing the importance of proper diagnosis.
To reduce transmission, he recommended avoiding overcrowded spaces, ensuring adequate ventilation, covering the mouth when coughing or sneezing, and refraining from sharing utensils. Participation in vaccination campaigns remains critical, he added.
“The high-risk period continues, and institutions must prioritize ventilation and promptly report suspected cases to health authorities to prevent further spread,” Dr. Idris said.